Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Minimally Invasive Surgery for Gynecologic Cancers—A Cautionary Tale

Minimally Invasive Surgery for Gynecologic Cancers—A Cautionary Tale Editorial Opinion ARTICLE INFORMATION Transplant. 2004;34(5):391-397. doi:10.1038/sj. 10. Hamadani M, Saber W, Ahn KW, et al. Impact of bmt.1704600 pretransplantation conditioning regimens on Author Affiliations: Department of Oncology, outcomes of allogeneic transplantation for Juravinski Hospital and Cancer Centre–Hamilton 4. Couban S, Simpson DR, Barnett MJ, et al; chemotherapy-unresponsive diffuse large B cell Health Sciences, McMaster University, Hamilton, Canadian Bone Marrow Transplant Group. lymphoma and grade III follicular lymphoma. Biol Ontario, Canada. A randomized multicenter comparison of bone Blood Marrow Transplant. 2013;19(5):746-753. marrow and peripheral blood in recipients of Corresponding Author: Ralph M. Meyer, MD, doi:10.1016/j.bbmt.2013.01.024 matched sibling allogeneic transplants for myeloid Juravinski Hospital and Cancer Centre, 699 malignancies. Blood. 2002;100(5):1525-1531. doi: 11. Yerushalmi R, Shem-Tov N, Danylesko I, Avigdor Concession St, Hamilton, ON L8V 5C2, Canada 10.1182/blood-2002-01-0048 A, Nagler A, Shimoni A. Fludarabine and treosulfan (meyerr@hhsc.ca). compared with other reduced-intensity 5. Powles R, Mehta J, Kulkarni S, et al. Allogeneic Published Online: June 4, 2020. conditioning regimens for allogeneic stem cell blood and bone-marrow stem-cell transplantation doi:10.1001/jamaoncol.2020.1303 transplantation in patients with lymphoid in haematological malignant diseases: a randomised Conflict of Interest Disclosures: Dr Berg reported malignancies. Bone Marrow Transplant. 2015;50 trial. Lancet. 2000;355(9211):1231-1237. serving as a consultant to Riemser http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

Minimally Invasive Surgery for Gynecologic Cancers—A Cautionary Tale

JAMA Oncology , Volume 6 (7) – Jul 11, 2020

Loading next page...
 
/lp/american-medical-association/minimally-invasive-surgery-for-gynecologic-cancers-a-cautionary-tale-rxXO1YN9OR
Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
2374-2437
eISSN
2374-2445
DOI
10.1001/jamaoncol.2020.1617
Publisher site
See Article on Publisher Site

Abstract

Editorial Opinion ARTICLE INFORMATION Transplant. 2004;34(5):391-397. doi:10.1038/sj. 10. Hamadani M, Saber W, Ahn KW, et al. Impact of bmt.1704600 pretransplantation conditioning regimens on Author Affiliations: Department of Oncology, outcomes of allogeneic transplantation for Juravinski Hospital and Cancer Centre–Hamilton 4. Couban S, Simpson DR, Barnett MJ, et al; chemotherapy-unresponsive diffuse large B cell Health Sciences, McMaster University, Hamilton, Canadian Bone Marrow Transplant Group. lymphoma and grade III follicular lymphoma. Biol Ontario, Canada. A randomized multicenter comparison of bone Blood Marrow Transplant. 2013;19(5):746-753. marrow and peripheral blood in recipients of Corresponding Author: Ralph M. Meyer, MD, doi:10.1016/j.bbmt.2013.01.024 matched sibling allogeneic transplants for myeloid Juravinski Hospital and Cancer Centre, 699 malignancies. Blood. 2002;100(5):1525-1531. doi: 11. Yerushalmi R, Shem-Tov N, Danylesko I, Avigdor Concession St, Hamilton, ON L8V 5C2, Canada 10.1182/blood-2002-01-0048 A, Nagler A, Shimoni A. Fludarabine and treosulfan (meyerr@hhsc.ca). compared with other reduced-intensity 5. Powles R, Mehta J, Kulkarni S, et al. Allogeneic Published Online: June 4, 2020. conditioning regimens for allogeneic stem cell blood and bone-marrow stem-cell transplantation doi:10.1001/jamaoncol.2020.1303 transplantation in patients with lymphoid in haematological malignant diseases: a randomised Conflict of Interest Disclosures: Dr Berg reported malignancies. Bone Marrow Transplant. 2015;50 trial. Lancet. 2000;355(9211):1231-1237. serving as a consultant to Riemser

Journal

JAMA OncologyAmerican Medical Association

Published: Jul 11, 2020

References